SIGA vs IRWD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IRWD Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ironwood Pharmaceuticals, Inc. - Class A (IRWD) driven by superior Growth & Margin, Momentum & Technical while SIGA counters with relative strength in Valuation, Options & Structure. Fundamentally, SIGA trades at 2.5x Forward P/E with -14.2% operating margin (-49.7% YoY revenue) versus IRWD at 12.3x Forward P/E and 62.9% operating margin (+9.0% YoY). In options structure, SIGA sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against IRWD sits in CONSOLIDATION (14th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SIGA Revenue | IRWD Revenue | SIGA Op. Margin | IRWD Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $480M | $350M | 74.4% | -43.5% | SIGA |
| FY2019 | $30M | $430M | -8.7% | 28.0% | IRWD |
| FY2020 | $120M | $390M | 67.6% | 36.7% | SIGA |
| FY2021 | $130M | $410M | 66.7% | 56.1% | SIGA |
| FY2022 | $110M | $410M | 38.5% | 61.0% | IRWD |
| FY2023 | $140M | $440M | 59.8% | -213.5% | SIGA |
| FY2024 | $140M | $350M | 50.4% | 26.5% | SIGA |
| FY2025 | $90M | $300M | 25.1% | 33.3% | IRWD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SIGA | IRWD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $187.9M | $791.3M | Larger Scale | IRWD |
| Trailing P/E Ratio Valuation | N/M | 5.3x | Lower Multiple | IRWD |
| Forward P/E Ratio Valuation | 2.5x | 12.3x | Lower Multiple | SIGA |
| Revenue Growth (YoY) Growth | -49.7% | +9.0% | Higher Growth | IRWD |
| Operating Margin (TTM) Profitability | -14.2% | 62.9% | Higher Margin | IRWD |
| Net Profit Margin Profitability | 1.3% | 37.4% | Higher Margin | IRWD |
| Return on Equity (ROE) Capital Efficiency | 0.4% | -574.7% | Higher ROE | SIGA |
| 52-Week Range Position Momentum | 3% ($3โ$7) | 62% ($3โ$6) | Stronger Trend | IRWD |
| Beta / 30D Volatility Risk Regime | 0.75ฮฒ ยท 65% Vol | 1.31ฮฒ ยท 54% Vol | Lower Realized Risk | IRWD |
| Unified Institutional Score Composite Signal | 47.5 / 100 (HOLD) | 37.5 / 100 (SELL) | Higher Composite | SIGA |